| scholarly article | Q13442814 |
| P2093 | author name string | Michael Lagunoff | |
| Terri A Dimaio | |||
| P2860 | cites work | Identification of cellular genes targeted by KSHV-encoded microRNAs | Q21131610 |
| Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways | Q24534690 | ||
| Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells | Q24555724 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation | Q28285842 | ||
| Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting | Q28298681 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion | Q28472867 | ||
| Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo | Q28586040 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Identification of microRNAs of the herpesvirus family | Q29618671 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus | Q30311122 | ||
| Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus | Q30439948 | ||
| Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. | Q30653484 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. | Q33283844 | ||
| Kaposin-B Enhances the PROX1 mRNA Stability during Lymphatic Reprogramming of Vascular Endothelial Cells by Kaposi's Sarcoma Herpes Virus | Q33668719 | ||
| Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. | Q33817882 | ||
| Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects | Q33849065 | ||
| Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus | Q33883910 | ||
| The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. | Q34046103 | ||
| Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma | Q34069841 | ||
| Latent KSHV Infection of Endothelial Cells Induces Integrin Beta3 to Activate Angiogenic Phenotypes | Q34102739 | ||
| Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse | Q34471059 | ||
| Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. | Q34513991 | ||
| Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. | Q34548882 | ||
| G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator | Q42833351 | ||
| Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. | Q44166149 | ||
| Viral IL-6-induced cell proliferation and immune evasion of interferon activity | Q44218062 | ||
| Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. | Q44277985 | ||
| Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. | Q46029178 | ||
| The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors | Q47755368 | ||
| Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus | Q53347753 | ||
| Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus | Q56794246 | ||
| Vascular Endothelial Growth Factor-C (VEGF-C) and its Receptors KDR and flt-4 are Expressed in AIDS-Associated Kaposi’s Sarcoma | Q57382283 | ||
| PAX2 expression by HHV-8-infected endothelial cells induced a proangiogenic and proinvasive phenotype | Q58620070 | ||
| Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF- B pathway | Q58620073 | ||
| Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
| Prox1 function is required for the development of the murine lymphatic system | Q73025820 | ||
| Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3 | Q74489252 | ||
| Activation of proMMP-2 and Src by HHV8 vGPCR in human pulmonary arterial endothelial cells | Q79450896 | ||
| The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility | Q84470156 | ||
| Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? | Q34996973 | ||
| Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells | Q35128724 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation | Q35137826 | ||
| Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors | Q35139228 | ||
| Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus | Q35453802 | ||
| Latent KSHV infection increases the vascular permeability of human endothelial cells | Q35553639 | ||
| Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma | Q35745558 | ||
| Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development | Q35765203 | ||
| Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1 | Q35785255 | ||
| Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor | Q35788580 | ||
| Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases | Q35914351 | ||
| The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. | Q36433542 | ||
| KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin‐induced signal transduction | Q36457808 | ||
| Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells | Q36845797 | ||
| Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin | Q36974720 | ||
| VEGF in biological control. | Q36989723 | ||
| Kaposi's sarcoma-associated herpesvirus-G protein-coupled receptor-expressing endothelial cells exhibit reduced migration and stimulated chemotaxis by chemokine inverse agonists | Q37196331 | ||
| Positive and negative modulation of angiogenesis by VEGFR1 ligands | Q37401612 | ||
| Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells | Q38348410 | ||
| Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. | Q38889973 | ||
| Immunostaining for CD31 and CD34 in Kaposi sarcoma | Q39658331 | ||
| Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor. | Q39659259 | ||
| Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus | Q39729318 | ||
| KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming | Q39751014 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 | Q39881608 | ||
| Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis | Q39892759 | ||
| Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression | Q40002571 | ||
| Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications | Q40040603 | ||
| A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia | Q40106826 | ||
| Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression | Q40173444 | ||
| Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease | Q40177470 | ||
| Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression | Q40267788 | ||
| B-Raf-dependent expression of vascular endothelial growth factor-A in Kaposi sarcoma-associated herpesvirus-infected human B cells. | Q40459751 | ||
| Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection | Q40598301 | ||
| Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant | Q40797202 | ||
| The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. | Q40814685 | ||
| KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells | Q40901369 | ||
| Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines | Q41088030 | ||
| Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation | Q41133441 | ||
| Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells | Q42141115 | ||
| The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha | Q42796220 | ||
| Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. | Q42814766 | ||
| P304 | page(s) | 102 | |
| P577 | publication date | 2012-03-30 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes | |
| P478 | volume | 3 |
| Q36336086 | An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes |
| Q47552839 | Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis |
| Q57040576 | Endothelins in inflammatory neurological diseases |
| Q36911706 | Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. |
| Q38611188 | Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells |
| Q39585656 | For the Future Studies of Kaposi’s Sarcoma-Associated Herpesvirus |
| Q38610039 | Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs |
| Q49363063 | KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis. |
| Q93074235 | KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation |
| Q26750211 | Lymph vessels: the forgotten second circulation in health and disease |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q92586530 | STING is dispensable during KSHV infection of primary endothelial cells |
| Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |
Search more.